ArticleBMC women's health2026
Postmenopausal vulvar hemangioma: diagnostic insights from a low-resource setting.
Article in BMC women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVulvar hemangiomas are rare in adults, particularly among postmenopausal women, often leading to clinical misdiagnosis. In resource-constrained settings, the lack of advanced imaging and immunohistochemistry (IHC) necessitates a heavy reliance on histopathological evaluation. This report highlights the importance of including benign vascular tumors in the differential diagnosis of adult vulvar masses to ensure accurate management. CASE PRESENTATION: A 62-year-old postmenopausal woman presented with a two-month history of a painless, firm, non-pulsatile mass on the left labia majora measuring 1.2 × 0.7 × 0.5 cm. Given the lesion's mobility and the absence of high-flow features or regional lymphadenopathy, an excisional biopsy was performed to achieve both diagnosis and therapy. Although the absence of preoperative imaging limited the initial assessment of vascular flow, meticulous histopathological examination revealed a well-circumscribed dermal proliferation of bland, variably sized vascular channels associated with a reactive lymphoplasmacytic infiltrate. A diagnosis of vulvar hemangioma was established via meticulous morphological assessment, successfully excluding malignancy despite the lack of IHC.
conclusionThis report contributes to the limited literature on geriatric vulvar hemangiomas by demonstrating that a de novo presentation in a postmenopausal woman can be definitively managed without advanced diagnostic technology. It establishes that in low-resource settings, meticulous hematoxylin and eosin-based morphological assessment is a robust standard for excluding malignancy, thereby preventing over-treatment and ensuring cost-effectively successful surgical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.